Drew M. Pardoll

1.4k total citations
16 papers, 1.1k citations indexed

About

Drew M. Pardoll is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Drew M. Pardoll has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Drew M. Pardoll's work include Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (4 papers). Drew M. Pardoll is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (5 papers) and Virus-based gene therapy research (4 papers). Drew M. Pardoll collaborates with scholars based in United States, Italy and Germany. Drew M. Pardoll's co-authors include B. J. Fowlkes, Elizabeth M. Jaffee, Florencia McAllister, Jennifer M. Bailey, Yanique Rattigan, Rajni Sharma, Charles G. Drake, Hongni Fan, Anirban Maitra and Jay K. Kolls and has published in prestigious journals such as Immunity, The Journal of Immunology and Cancer Cell.

In The Last Decade

Drew M. Pardoll

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Drew M. Pardoll United States 8 731 426 319 155 72 16 1.1k
Jin‐Hao Yang China 12 502 0.7× 519 1.2× 286 0.9× 148 1.0× 59 0.8× 27 955
Anna Kwilas United States 16 457 0.6× 587 1.4× 240 0.8× 95 0.6× 49 0.7× 24 969
I G Schmidt-Wolf Germany 13 636 0.9× 653 1.5× 190 0.6× 83 0.5× 28 0.4× 24 1.0k
Naira E. Souleimanian United States 12 724 1.0× 202 0.5× 531 1.7× 96 0.6× 56 0.8× 14 1.2k
Shinya Hirata Japan 20 635 0.9× 424 1.0× 516 1.6× 54 0.3× 32 0.4× 44 1.1k
Nan Ring United States 7 782 1.1× 464 1.1× 258 0.8× 58 0.4× 107 1.5× 12 1.1k
Rodney A. Prell United States 15 1.0k 1.4× 563 1.3× 220 0.7× 62 0.4× 143 2.0× 24 1.3k
Mobin Karimi United States 11 524 0.7× 414 1.0× 291 0.9× 71 0.5× 42 0.6× 32 927
Paola Porcedda Italy 12 302 0.4× 250 0.6× 419 1.3× 124 0.8× 151 2.1× 17 800
Anna Morabito Italy 17 559 0.8× 447 1.0× 223 0.7× 83 0.5× 43 0.6× 37 992

Countries citing papers authored by Drew M. Pardoll

Since Specialization
Citations

This map shows the geographic impact of Drew M. Pardoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew M. Pardoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew M. Pardoll more than expected).

Fields of papers citing papers by Drew M. Pardoll

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Drew M. Pardoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew M. Pardoll. The network helps show where Drew M. Pardoll may publish in the future.

Co-authorship network of co-authors of Drew M. Pardoll

This figure shows the co-authorship network connecting the top 25 collaborators of Drew M. Pardoll. A scholar is included among the top collaborators of Drew M. Pardoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Drew M. Pardoll. Drew M. Pardoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Topalian, Suzanne L. & Drew M. Pardoll. (2025). Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care. Journal for ImmunoTherapy of Cancer. 13(1). e010833–e010833. 6 indexed citations
2.
Sloan, Lindsey, Rupashree Sen, Michèle Doucet, et al.. (2024). Radiation immunodynamics in patients with glioblastoma receiving chemoradiation. Frontiers in Immunology. 15. 1438044–1438044. 3 indexed citations
3.
Sidhom, John-William, Debebe Theodros, Jelani C. Zarif, et al.. (2019). ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data. Journal of Visualized Experiments. 2 indexed citations
4.
Muroyama, Yuki, Thomas R. Nirschl, Christina M. Kochel, et al.. (2017). Stereotactic radiotherapy increases functionally suppressive regulatory T cells in the tumor microenvironment. The Journal of Immunology. 198(Supplement_1). 204.19–204.19. 5 indexed citations
5.
McAllister, Florencia, Jennifer M. Bailey, Janivette Alsina, et al.. (2014). Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia. Cancer Cell. 25(5). 621–637. 305 indexed citations
6.
Bettini, Matthew L., Fan Pan, Maria Bettini, et al.. (2012). Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency. Immunity. 36(5). 717–730. 126 indexed citations
7.
Lesniak, Maciej S., Betty Tyler, Drew M. Pardoll, & Henry Brem. (2003). Gene Therapy for Experimental Brain Tumors Using a Xenogenic Cell Line Engineered to Secrete hIL-2. Journal of Neuro-Oncology. 64(1). 155–160. 1 indexed citations
8.
Chang, Edwin Y., Chien‐Hung Chen, Hongxiu Ji, et al.. (2000). Antigen‐specific cancer immunotherapy using a GM‐CSF secreting allogeneic tumor cell‐based vaccine. International Journal of Cancer. 86(5). 725–730. 7 indexed citations
9.
Lesniak, Maciej S., Prakash Sampath, Francesco DiMeco, et al.. (2000). Comparative analysis of paracrine immunotherapy in experimental brain tumors. Neurosurgical FOCUS. 9(6). 1–6. 8 indexed citations
10.
Pardoll, Drew M.. (2000). Therapeutic Vaccination for Cancer. Clinical Immunology. 95(1). S44–S62. 61 indexed citations
11.
DiMeco, Francesco, Laurence D. Rhines, Justin Hanes, et al.. (2000). Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. Journal of neurosurgery. 92(3). 419–427. 50 indexed citations
12.
Ji, Hongxiu, et al.. (1998). Antigen‐specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. International Journal of Cancer. 78(1). 41–45. 5 indexed citations
13.
Fort, Madeline & Drew M. Pardoll. (1996). Can Bone Marrow-Derived Thymic Stromal Cells Mediate the Positive Selection of Class I-Restricted T Cells?. Cellular Immunology. 171(1). 74–79. 5 indexed citations
14.
Thompson, Reid C., Drew M. Pardoll, Elizabeth M. Jaffee, et al.. (1996). Systemic and Local Paracrine Cytokine Therapies Using Transduced Tumor Cells Are Synergistic in Treating Intracranial Tumors. Journal of Immunotherapy. 19(6). 405–413. 50 indexed citations
15.
Golumbek, Paul T., Fayez M. Hamzeh, Elizabeth M. Jaffee, et al.. (1992). Herpes Simplex-1 Virus Thymidine Kinase Gene Is Unable to Completely Eliminate Live, Nonimmunogenic Tumor Cell Vaccines. Journal of Immunotherapy. 12(4). 224–230. 53 indexed citations
16.
Fowlkes, B. J. & Drew M. Pardoll. (1989). Molecular and Cellular Events of T Cell Development. Advances in immunology. 44. 207–264. 410 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026